España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Altimmune
ALT
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$8.04
-0.01
-0.12%
Pre-Market: 6:31 AM EDT
Get Report
Comment
Altimmune (ALT) Forecast
News
Earnings
Altimmune (ALT) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Altimmune (NASDAQ:ALT) Stock
Altimmune Stock (NASDAQ: ALT)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Friday, November 15, 2024
Altimmune Presents New Data On The Effect Of ...
Benzinga Newsdesk
Thursday, November 14, 2024
HC Wainwright & Co. Reiterates Buy on Altimmu...
Benzinga Newsdesk
Wednesday, November 13, 2024
Altimmune Unusual Options Activity For November 13
Benzinga Insights
10 Health Care Stocks With Whale Alerts In Today's Session
Benzinga Insights
Tuesday, November 12, 2024
Tyson Foods Posts Better-Than-Expected Earnings, Joins Shopify, Sea, Buckle And Other Big Stocks Moving Higher On Tuesday
Avi Kapoor
Altimmune shares are trading higher after the...
Benzinga Newsdesk
This Nvidia Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
Avi Kapoor
UBS Initiates Coverage On Altimmune with Buy ...
Benzinga Newsdesk
Altimmune Q3 2024 GAAP EPS $(0.32) Beats $(0....
Benzinga Newsdesk
Earnings Scheduled For November 12, 2024
Benzinga Insights
Monday, November 11, 2024
Altimmune Appoints Greg Weaver As Chief Finan...
Benzinga Newsdesk
Thursday, November 07, 2024
Altimmune shares are trading higher after the...
Benzinga Newsdesk
Altimmune Announces Completion Of End-of-Phas...
Benzinga Newsdesk
Tuesday, October 15, 2024
Altimmune To Present New Data On The Lipidomi...
Benzinga Newsdesk
Friday, October 11, 2024
Novo Nordisk, Eli Lilly Could Face Downward Pressure Despite Market Dominance From Potentially 16 New Obesity Drugs: See The Names
Vandana Singh
Monday, September 30, 2024
Altimmune Has Completed Patient Enrollment In...
Benzinga Newsdesk
Tuesday, September 10, 2024
Altimmune shares are trading higher after the...
Benzinga Newsdesk
Altimmune Corrects Previous Release; Says Red...
Benzinga Newsdesk
Altimmune Presents Data From Its Phase 2, MRI...
Benzinga Newsdesk
Thursday, August 22, 2024
Decoding 4 Analyst Evaluations For Altimmune
Benzinga Insights
HC Wainwright & Co. Reiterates Buy on Altimmu...
Benzinga Newsdesk
Monday, August 12, 2024
B. Riley Securities Reiterates Buy on Altimmu...
Benzinga Newsdesk
Thursday, August 08, 2024
Altimmune shares are trading higher. The comp...
Benzinga Newsdesk
CORRECTION: Altimmune Q2 2024 GAAP EPS $(0.35...
Benzinga Newsdesk
Thursday, June 27, 2024
Shares of Altimmune are trading higher after ...
Benzinga Newsdesk
Watching Altimmune; Traders Circulate New Yor...
Benzinga Newsdesk
Wednesday, June 26, 2024
Why Are Altimmune Shares Trading Lower Wednesday?
Vaishali Prayag
Altimmune shares are trading lower following ...
Benzinga Newsdesk
Altimmune Announces Passing Of Chief Financia...
Benzinga Newsdesk
Tuesday, June 25, 2024
B. Riley Securities Reiterates Buy on Altimmu...
Benzinga Newsdesk
Monday, June 24, 2024
Altimmune Stock Is Rising Monday: What's Driving The Action?
Adam Eckert
Market-Moving News for June 24th
Benzinga Newsdesk
RXO, Alnylam Pharmaceuticals And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Avi Kapoor
Altimmune shares are trading higher after the...
Benzinga Newsdesk
Sunday, June 23, 2024
Altimmune Presents Data Sunday From Phase 2 M...
Benzinga Newsdesk
Friday, June 21, 2024
Forecasting The Future: 5 Analyst Projections For Altimmune
Benzinga Insights
Piper Sandler Maintains Overweight on Altimmu...
Benzinga Newsdesk
Wednesday, June 05, 2024
Altimmune Presents New Data on Pemvidutide's ...
Benzinga Newsdesk
Monday, June 03, 2024
How Is The Market Feeling About Altimmune?
Benzinga Insights
Friday, May 17, 2024
4 Stocks That Could Break Novo Nordisk, Lilly's Obesity Duopoly
Zacks
Tuesday, May 14, 2024
HC Wainwright & Co. Reiterates Buy on Altimmu...
Benzinga Newsdesk
Friday, May 10, 2024
JMP Securities Maintains Market Outperform on...
Benzinga Newsdesk
Thursday, May 09, 2024
Altimmune Q1 2024 GAAP EPS $(0.34) Beats $(0....
Benzinga Newsdesk
Tuesday, May 07, 2024
Jim Cramer Calls Nutanix 'The Perfect Enterprise Software Company For The Moment'
Avi Kapoor
Tuesday, April 30, 2024
Peering Into Altimmune's Recent Short Interest
Benzinga Insights
Monday, April 29, 2024
Why Clever Leaves Holdings Shares Are Trading Lower By Around 60%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Avi Kapoor
Deutsche Bank, Daqo New Energy And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Avi Kapoor
Altimmune shares are trading lower after Gugg...
Benzinga Newsdesk
Guggenheim Downgrades Altimmune to Neutral
Benzinga Newsdesk
Monday, April 08, 2024
How Is The Market Feeling About Altimmune?
Benzinga Insights
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch